Physician

Christopher Raymond Phillips, M.D.

According to 2025 Medicare claims, Christopher Phillips, M.D. (NPI: 1912024563) practices rheumatology in the Paducah, KY-IL market, with the plurality of this provider's patient population coming from Mc Cracken, KY. This provider's primary affiliated billing organization is RHEUMATOLOGY SPECIALISTS OF PADUCAH PLLC (NPI: 1902380082; TIN: 831140976) and primary practice location at 42001-6787. Phillips is affiliated with the IRCCO (ACO ID: A2619), The Rural Advantage LLC (ACO ID: A5257), and IHCI ACO Midwest LLC (ACO ID: A5516), participating under the MSSP model.

Phillips' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,054 traditional Medicare patients, billed 418,608 HCPCS/CPT codes, and received $3,600,797 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 11,676 prescription claims across 1,508 beneficiaries totaling $8,786,808 in drug costs, led by Enbrel Sureclick (Etanercept). 2017 DME data shows 23 claims. Open Payments data shows 86 records totaling $1,637. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,785,344 to $3,600,797. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,610,799 to $8,786,808. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	868	151,082	$1,785,344
2016	932	182,865	$1,986,106
2017	926	208,965	$2,346,522
2018	1,195	258,280	$3,207,086
2019	1,161	275,180	$3,367,880
2020	1,132	322,187	$3,931,365
2021	1,047	291,808	$3,161,724
2022	1,023	303,398	$2,858,309
2023	1,017	343,230	$2,998,934
2024	1,054	418,608	$3,600,797

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	674	7,758	$1,610,799
2016	772	8,545	$1,952,111
2017	785	8,480	$2,240,123
2018	1,125	10,547	$3,684,809
2019	1,234	10,951	$4,687,732
2020	1,330	11,401	$5,505,720
2021	1,425	11,279	$6,780,914
2022	1,429	11,035	$7,341,517
2023	1,438	11,023	$8,484,402
2024	1,508	11,676	$8,786,808

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	23	$375
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	563	752	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	256	262	$61
86225	Measurement of dna antibody, native or double stranded	223	226	$13
86226	Measurement of dna antibody, single stranded	222	225	$12
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	518	638	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	248	7,176	$1,878,983
Humira(Cf) Pen	Adalimumab	191	6,002	$1,627,293
Rinvoq	Upadacitinib	205	7,290	$1,562,046
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	13	364	$390,356
Otezla	Apremilast	43	1,590	$256,475

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	86	$1,637	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Raymond Phillips, M.D.?

Tedicare shows public-source Medicare data for Christopher Raymond Phillips, M.D. (NPI 1912024563), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Raymond Phillips, M.D. have ACO affiliation data?

Christopher Raymond Phillips, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), The Rural Advantage LLC (MSSP, ACO ID A5257), and IHCI ACO Midwest LLC (MSSP, ACO ID A5516).

What billing organization is linked to Christopher Raymond Phillips, M.D.?

Christopher Raymond Phillips, M.D. is linked to RHEUMATOLOGY SPECIALISTS OF PADUCAH PLLC (billing NPI 1902380082) in the available physician profile data.

Does Christopher Raymond Phillips, M.D. have Open Payments data?

Christopher Raymond Phillips, M.D. has 86 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.